T1	Treatment 0 11	Nateglinide
T2	Treatment 277 300	strict glycemic control
T3	Treatment 521 591	78 drug-naive type 2 diabetic patients whose HbA1c was less than 6.5%.
T4	Treatment 648 711	nateglinide (270 mg/dL) and 40 to control group (no treatment).
T5	Treatment 1013 1028	untreated group
T6	Treatment 1422 1460	strict glycemic control by nateglinide
